Recent Advances in the Treatment and Management of NASH.
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States (U.S.) and is soon to be the leading cause of liver transplantation. Patients at the greatest risk are those with obesity and type 2 diabetes. Weight loss and several pharmacological treatments can...
| Publicado en: | Journal of Managed Care Medicine Vol. 24; no. 2; pp. 37 - 42 |
|---|---|
| Autor principal: | |
| Formato: | tables/charts Journal Article |
| Publicado: |
National Association of Managed Care Physicians, Inc.
2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States (U.S.) and is soon to be the leading cause of liver transplantation. Patients at the greatest risk are those with obesity and type 2 diabetes. Weight loss and several pharmacological treatments can often be successful to reverse steatohepatitis and prevent disease progression. |
|---|